Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Inventory (2016 - 2019)

Aptevo Therapeutics (APVO) has disclosed Inventory for 5 consecutive years, with $6.1 million as the latest value for Q4 2019.

  • Quarterly Inventory rose 243.92% to $6.1 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2019, up 243.92% year-over-year, with the annual reading at $6.1 million for FY2019, 243.92% up from the prior year.
  • Inventory hit $6.1 million in Q4 2019 for Aptevo Therapeutics, down from $7.5 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $20.3 million in Q4 2015 to a low of $461000.0 in Q4 2016.
  • Historically, Inventory has averaged $6.6 million across 5 years, with a median of $5.2 million in 2019.
  • Biggest five-year swings in Inventory: tumbled 97.73% in 2016 and later soared 243.92% in 2019.
  • Year by year, Inventory stood at $20.3 million in 2015, then crashed by 97.73% to $461000.0 in 2016, then surged by 122.99% to $1.0 million in 2017, then skyrocketed by 73.64% to $1.8 million in 2018, then skyrocketed by 243.92% to $6.1 million in 2019.
  • Business Quant data shows Inventory for APVO at $6.1 million in Q4 2019, $7.5 million in Q3 2019, and $7.0 million in Q2 2019.